|
Committee on the Prevention of HIV Infection
among Injecting Drug Users in High Risk Countries
Meeting Agenda
December 19-20, 2005
Location: The International Labour Organization (ILO)
4 route de Morillons
Geneva, Switzerland
OPEN SESSION
9:00 - 9:15 a.m. Welcome, Introductions, and Opening Statement
Hugh Tilson, M.D., Dr.PH.
Committee Chair
9:15 - 9:45 a.m. Charge to the committee
Peter Piot, M.D., Ph.D.
Executive Director, UNAIDS
Under Secretary-General of the United Nations
9:45 - 10:15a.m. Overview of addiction
Michael Farrell, MRCPsych
Reader in Addiction Psychiatry, National Addiction Centre
Institute of Psychiatry
King's College, London
View presentation
10:15 - 11:00 a.m. Epidemiology of HIV/AIDS among IDUs in High-Risk Countries and the Global Response
Dr. Peter Ghys
Acting Associate Director, Epidemic Monitoring and Prevention, Department of Policy, Evidence and Partnerships
UNAIDS
View presentation
Catherine Anita Hankins, MD, MSc, FRCPC
Associate Director of Policy, Evidence and Partnerships
Chief Scientific Adviser
UNAIDS
View presentation
11:00 - 11:15 a.m. Break
11:15a.m. - 12:45 pm Evidence regarding HIV Prevention for IDUs
Overview:
Gerry V. Stimson PhD
Emeritus Professor, Imperial College London, and
Executive Director, International Harm Reduction Association
View presentation
Review of needle and syringe exchange programs:
Dr. Alex Wodak FRACP, FChAM
Director, Alcohol and Drug Service
St. Vincent's Hospital, Darlinghurst
Australia
View presentation
Review of needle and syringe exchange programs:
Kerstin Kall, MD, Ph.D.
Clinic for Dependency Disorders
University Hospital
Linkoping, Sweden
View presentation
Review of drug treatment strategies:
Michael Farrell, MRCPsych
Reader in Addiction Psychiatry, National Addiction Centre, Institute of Psychiatry
King's College, London
View presentation
12:45 - 1:45 p.m. Lunch
1:45 - 3:15p.m. Country Perspectives Panel – Asian and Pacific countries
Fujie Zhang, M.D.
Director, Division of Treatment and Care
National Center for AIDS-STD Control and Prevention
Chinese Center for Disease of Control and Prevention
View presentation
Adeeba Kamarulzaman, MBBS, FRACP
Head, Infectious Diseases Unit
Department of Medicine
University of Malaya Medical Centre
Malaysia
View presentation
Chris Beyrer, MD, MPH
Associate Professor, Department of Epidemiology
Director, Johns Hopkins Fogarty AIDS International Training and Research Program
Director, Johns Hopkins Center for Public Health & Human Rights
Johns Hopkins Bloomberg School of Public Health
(discussing Thailand)
View presentation
3:15 - 3:30p.m. Break
3:30 - 5:45 p.m. Country Perspectives Panel–Former Soviet States, Central and Eastern European countries
Saulius Caplinskas, M.D., Ph.D.
Director, Lithuanian AIDS Centre
Associate Professor, Mykolas Romeris University
View presentation
Monica Ciupagea M.D.
Program Officer
International Harm Reduction Development Program
Open Society Institute, Budapest
View presentation
Dr. Oleg Tchestnov
Deputy Director of the International Department
Ministry of Health, Russia
Ksenia Eroshina, MPH, Ph.D.
Head of Monitoring & Evaluation Department
Open Health Institute, Moscow, Russia
View presentation
Alexey Mazus M.D.
Head of Moscow AIDS Center
View presentation
Inga Upmace, M.D.
Deputy Director, AIDS Prevention Center, Latvia
Steering Commitee member of CEE-HRN (Central and Eastern Europe Harm Reduction Network)
View presentation
Lily Hyde
Harm reduction and IEC Consultant
International HIV/AIDS Alliance in Ukraine
6:30 p.m. Reception for all meeting participants at the ILO building, hosted by UNAIDS
December 20th
OPEN SESSION
8:30 - 10:00 a.m. Lessons Learned– Experiences in the U.S., Canada, Australia, and Western European countries
Don C. Des Jarlais, Ph.D.
Director of Research, Baron Edmond de Rothschild Chemical Dependency Institute,
Beth Israel Medical Center
Professor of Epidemiology, Department of Epidemiology and Population Health
Albert Einstein College of Medicine, New York
View presentation
Dr. Alex Wodak FRACP, FChAM
Director, Alcohol and Drug Service
St. Vincent's Hospital, Darlinghurst
Australia
View presentation
Roel A. Coutinho, M.D., Ph.D.
Director, Centre for Infectious Disease Control
National Institute for Health and the Environment
The Netherlands
View presentation
Gerry V. Stimson PhD
Emeritus Professor, Imperial College London, and
Executive Director, International Harm Reduction Association
View presentation
10:00a.m. - 10:15a.m. Break
10:15a.m. - 12:30p.m. Illicit drug policies and the HIV epidemic
Andrew Ball MB BS, FAChAM
Senior Strategy and Operations Advisor
Department of HIV/AIDS
World Health Organization
View presentation
Mr. Christian Kroll
Senior Coordinator, HIV/AIDS Unit
Global Coordinator on HIV/AIDS
UNODC
View presentation
Chris Beyrer, MD, MPH
Associate Professor, Department of Epidemiology
Director, Johns Hopkins Fogarty AIDS International Training and Research Program
Director, Johns Hopkins Center for Public Health & Human Rights
Johns Hopkins Bloomberg School of Public Health
View presentation
Mr. Tomas Hallberg
Director, European Cities against Drugs (ECAD)
Stockholm, Sweden
View remarks
Mr. George Zazulin
St. Petersburg Regional Director, ECAD, Russia
Dr. Alex Wodak FRACP, FChAM
Director, Alcohol and Drug Service
St. Vincent's Hospital, Darlinghurst
Australia
View presentation
Ms. Raminta Stuikyte
Director, Central and Eastern European Harm Reduction Network
View presentation
12:30 - 1:30 p.m. Lunch
1:30 - 2:30pm Community Perspectives
Mr. Loon Gangte (unable to attend)
President, Delhi Network of Positive People, India
Regional Coordinator for South Asia
Collaborative Fund for HIV treatment Preparedness
View presentation and remarks
Mr. Samuel Nugraha
Partnership and Network Assistant
UNAIDS Secretariat Indonesia
View presentation
2:30 - 3:00 p.m. Methodological considerations in evaluating evidence
Don C. Des Jarlais, Ph.D.
Director of Research, Baron Edmond de Rothschild Chemical Dependency Institute,
Beth Israel Medical Center
Professor of Epidemiology, Department of Epidemiology and Population Health
Albert Einstein College of Medicine, New York
View presentation
3:00 - 3:30 p.m. Public comments
3:30 p.m. Adjourn open session
|